Patents by Inventor Steve Weitman

Steve Weitman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Effective Antitumor Treatments
    Publication number: 20120107417
    Abstract: ET-743 is used in the preparation of a medicament for an effective treatment of a tumour by combination therapy employing ET-743 with another drug.
    Type: Application
    Filed: December 30, 2011
    Publication date: May 3, 2012
    Applicant: PHARMA MAR, S.A.
    Inventors: Naoto Takahashi, Steve Weitman, Maurizio D'Incalci, Glynn Thomas Faircloth, Rafaella Giavazzi, Andreas Gescher
  • Effective Antitumor Treatments
    Publication number: 20090324744
    Abstract: ET-743 is used in the preparation of a medicament for an effective treatment of a tumour by combination therapy employing ET-743 with another drug.
    Type: Application
    Filed: September 2, 2009
    Publication date: December 31, 2009
    Applicant: PHARMA MAR, S.A.
    Inventors: Naoto Takahashi, Steve Weitman, Maurizio D'incalci, Glynn Thomas Faircloth, Rafaella Giavazzi, Andreas Gescher
  • Kahalalide F
    Patent number: 7473681
    Abstract: Formulations and uses of kahalalide F.
    Type: Grant
    Filed: October 31, 2001
    Date of Patent: January 6, 2009
    Assignee: Pharma Mar, S.A.
    Inventors: Glynn Thomas Faircloth, Bastiaan Nuijen, Steve Weitman
  • Effective antitumor treatments
    Publication number: 20040108086
    Abstract: ET-743 is used in the preparation of a medicament for an effective treatment of a tumour by combination therapy employing ET-743 with another drug.
    Type: Application
    Filed: September 17, 2003
    Publication date: June 10, 2004
    Inventors: Naoto Takahashi, Steve Weitman, Maurizio D'Incalci, Glynn Thomas Faircloth, Rafaella Giavazzi, Andreas Gescher
  • Kahalalide f formulation
    Publication number: 20040067895
    Abstract: New formulations and new uses of kahalalide F are provided.
    Type: Application
    Filed: November 14, 2003
    Publication date: April 8, 2004
    Inventors: Glynn Thomas Faircloth, Bastian Nuyen, Steve Weitman